TP53 and colorectal cancer: The majority of the pathways that were enriched in ccRCC and not pRCC are known to be involved in cancer development and progression such as p53 signaling, molecular mechanisms of cancer, apoptosis signaling and colorectal cancer metastasis signaling, while a link between pathways specific to pRCC and cancer was not apparent.